Archive

 

 

Successfull cooperation with Medical Enzymes AG

 

 

 

>

In cooperation with the Berlin biotechnology company, Medical Enzymes AG, a new enzymatic tumor treatment is investigated in clinical trials at ZAFES. With this treatment, a naturally occuring enzyme catalyzes the cleavage of a cell growth promoting amino acid. Thus, this amino acid is no longer available for growth processes. The method takes advantage of the fact that cancer cells are more dependent on certain amino acids than regular cells. The adminstration of the enzyme that cleaves the amino acid results in “starving” the cancer cells.
Initially ZAFES started a clinical trial for the colon cancer indication. Now, the clinical studies are extended to indications such as lung and kidney cancer. In the cooperation with ZAFES the industrial partner Medical Enzymes AG benefits from the numerous medical centers that are members of ZAFES. These centers have access to high numbers of patients and assure the fast accomplishment of clinical trials. ZAFES coordinates the project and is the compent contact for Medical Enzymes AG.

 

 

< back

 

NEWS

 

UP TO DATE

 
 
 

ZAFES BROCHURE

 
 

ZAFES KICK OFF SYMPOSIUM